Anti-Fibrotic Effects of Pirfenidone and Rapamycin in Primary IPF Fibroblasts and Human Alveolar Epithelial Cells

BMC Pulmonary Medicine - United Kingdom
doi 10.1186/s12890-018-0626-4

Related search